BEDDINGFIELD III FREDERICK (President & CEO) reported 1 transaction at SIENNA BIOPHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/21/2018ACC: 0001562180-18-002587
DirectorOfficer· President & CEO
Since Jan 2019
+47.59K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
47.59K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+47.59K
Price / share
—
Trade value
—
% of position
8.6%
5/17/2018
553.65K→601.25K
Total
Net shares
+47.59K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/17/2018 | J · J | +47.59K | — | — | 8.6% | 553.65K | 601.25K |
| Total | +47.59K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned14.08K
Common Stock
IndirectShares owned14.08K
Common Stock
IndirectShares owned112.61K
Total
140.77K indirect140.77K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08K | Indirect |
| Common Stock | 14.08K | Indirect |
| Common Stock | 112.61K | Indirect |
| Total | 140.77K | 140.77K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported